glp-1 weight loss drug news Weight-loss, diabetes drugs linked to vision problems in small study New Research Uncovers Hidden Side

Diabetes Care, 48 (1 Suppl 1), S167S180

Semaglutide, which is also available under the brand names Ozempic and Rybelsus, is a GLP-1 receptor agonist that has been shown to help people with type 2 diabetes lose weight, lower glucose levels, and protect against diabetes-related heart complications

Longitudinal Assessment of Bariatric Surgery (LABS) Consortium

Macrophage polarization in physiological and pathological pregnancy

This was presented at the American Diabetes Association meeting and suggests that mazdutide, through its glucagon receptor activation, drives significant hepatic fat reduction

while in the UK over 400,000 patients paid out of pocket for AOMs